Research & Development: Page 47
-
PharmaVoice Team/PharmaVoice
Tools of the Trade
Deloitte Launches ExaLink, a Multi-Services Platform for Commercial Operations Trending now: New platform helps pharma companies transcend legacy enterprise systems. Deloitte has released a hybrid cloud-based, multi-services platform, ExaLink, to help life-sciences companies transform their comm...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Combination Products
Combination products are products that combine two or more different types of FDA-regulated products, including drugs, biologics, and medical devices. Regulators are working to make this process easier with the establishment of the Combination Product Council, identifying process improvements, an...
By PharmaVoice Team • Nov. 21, 2016 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Trending 2017: Industrial Internet
The Industrial Internet, a term coined by GE, is the integration of complex physical machinery with networked sensors and software. The next state of the Industrial Internet will enable artificial intelligence to make meaningful use of device-collected data. This near future state is generating e...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Smart Technology
The ability to capture health information in real time is changing the face of healthcare and clinical trials. Take for example Novartis and Qualcomm’s next-generation inhaler that enables patients to have access to their own data on the use of their inhaler in near real time. The small, disposab...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Talent War
For most organizations the war for talent isn’t just with their competitors; it’s a battle being waged on a global basis that transcends industries. As global megatrends escalate, companies are reshaping their businesses and innovating to meet new market demands. The challenge is talent innovatio...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Data-driven Site Selection Accelerating Your Trials Through Predictive Site Modeling
Accelerated study start-up is the universally acknowledged holy grail of streamlining clinical trial operations. While advancements like central IRB review, adaptive trial designs, and the implementation of electronic systems have led to increased efficiencies across the clinical trial enterprise...
By Suzanne Caruso • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Speak Out
Changing the Drug Development Playbook –MODEL-INFORMED DRUG DEVELOPMENT HAS ARRIVED Imagine that you can reduce the number of patients required for a complex, hard-torecruit clinical trial by ten-fold. Imagine that you can use technology alone to add dosing information for special populations – s...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Clinical Data in Real Time The number of clinical trials using mobile apps more than doubled, rising from 135 in 2014 to 300 in 2015, according to the IMS Health Study Patient Options Expand as Mobile Healthcare Apps Address Wellness and Chronic Disease Treatment Needs. No doubt when 2016 numbers...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large BMS Employees Cycle Coast to Coast to Raise Money for Cancer Research The first of six teams of Bristol-Myers Squibb oncology employees set out in September from Cannon Beach on the Oregon coast on the first leg of the 2016 Coast 2 Coast 4 Cancer Ride, a 21-day cycling ride that...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Era for “Bubble Boy" Disease Sven Kili, M.D., head of gene therapy development at GlaxoSmithKline, talks about the company’s gene therapy to treat a very rare immune system disorder, which recently received EU approval. Children born with a specific immune disorder — severe combined immunod...
By Sven Kili • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Global Site Solutions Summit, produced by the Society for Clinical Research Sites (SCRS), is committed to being “the site’s meeting." The conference provides a unique hub where sites, sponsors, CRO executives, and regulators come together and share best practices; build the...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Future of Research All the innovation that is happening in research labs around the globe may come to naught if the sites, patients, and physician investigators needed to move the science forward are not a substantive part of the equation. In this month’s cover story “Why Sites Matter," the c...
By Taren Grom • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large MMRF, Takeda, and CURE Media Join Forces to Support Hiking Team A team of 20 multiple myeloma patients, caregivers, physicians, nurses, and supporters hiked along Peru’s arduous Inca Trail leading to the ruins of Machu Picchu to raise funds for research and to build awareness ar...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Battery-less, Stretchable Patch Provides More Options for Health Monitoring Trending now: Innovative solutions lead to next generation mHealth tools. John Rogers, Ph.D., founder of MC10 and a materials scientist at the University of Illinois at Urbana-Champaign, has introduced a wearable electro...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Following the Science Bill Hinshaw, Executive VP and Head of Novartis Oncology US, talks about the company’s efforts to create innovation in the cancer arena. PV: What is Novartis doing to encourage innovation? Hinshaw: Transforming cancer care is a core part of our mission. Novartis as a corpora...
By Bill Hinshaw • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Why Sites Matter
Clinical sites face several challenges, including predictability of trial business, payments, and technology issues, in addition to a highly fragmented clinical trial landscape. Many of the challenges that sites face reflect the changing landscape of clinical research. Sites are responsible for m...
By Denise Myshko • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Principal Investigator Turnover
The principal investigator (PI) landscape is in flux. According a 2015 survey from the Tufts Center for the Study of Drug Development, persistently high turnover rates among PIs create instability and present an additional challenge for sponsors and CROs. While the number of investigators globall...
By Denise Myshko • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Company Launches to Address Preclinical Research Trending now: Vium aims to bridge the technology gap in preclinical research to accelerate drug development. Vium has officially launched, offering Digital Vivarium and Vium Cloud, which bridge a technology gap in preclinical in vivo drug rese...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Commanders & Chiefs Julie Adrian Chandler Chicco Agency, inVentiv Health Mary Anderson Ogilvy CommonHealth Medical Educatio...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Born Leaders A Global Perspective
This year, the homelands of the PharmaVOICE 100 account for almost 20 different countries or territories — from Russia to the West Indies, from Scotland to New Zealand, and from the United States to Australia and various points in between. Six of our honorees — Ken Keller, Stu Libby, Jennifer Mat...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Scurvy + Science In May 1747, the HMS Salisbury of Britain’s Royal Navy fleet was patrolling the English Channel at a time when scurvy is thought to have killed more British seamen than French and Spanish arms. According to the Association of Clinical Research Professionals (ACRP), aboard this sh...
By Taren Grom • June 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Sanofi Genzyme Donates Corporate Archives To Harvard Business School Sanofi Genzyme is donating materials to create an extensive archival collection, spanning the more than three decades since the company’s founding in 1981, to the Historical Collections of Harvard Business Scho...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A “Universal" Flu Vaccine in the Works Tim Alefantis, Ph.D., Sanofi Pasteur’s R&D lead on the second-generation vaccine program, and Sam Lee, Ph.D., project strategy for Sanofi Pasteur’s pandemic and new influenza vaccines, talk about the company’s work to develop a broadly effective influen...
By Tim Alefantis • June 1, 2016 -
PharmaVoice Team/PharmaVoice
2016 DIA Preview
This year’s annual meeting of the Drug Information Association is expected to draw more than 7,000 attendees for the largest global interdisciplinary gathering of life-sciences professionals. DIA 2016 is packed with more than 175 educational offerings over 22 tracks on today’s hottest topics, and...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
CNS Research Challenges
Neurological disorders consist of more than 600 conditions, impacting an estimated 50 million Americans every year. Although some are well known, many are rare disorders that affect a small number of patients who currently have access to few, if any, effective treatments. Research in the CNS area...
By Denise Myshko • June 1, 2016
Previous
